Worship, theology, and praxis at Antioch Community Church, Waltham, Massachusetts: an exploration of the foundations of worship from a Baptist-Charismatic perspective

This project thesis explores and identifies the foundational suppositions that undergird corporate worship at Antioch Community Church of Waltham (as part of Antioch Community Church of Greater Boston), and to that end examines the relationship between an articulated theology of worship and the worship praxis that simultaneously embodies and generates that theology. Research for this project included review of selected works on worship and liturgical theology, interpretation of significant biblical texts, an exploration of contemporary praise and worship music, the development and interpretation of a church survey, and a series of interviews and ethnographic investigations. This study shows that the church articulates its theology of worship within a scriptural framework and places a high value on encountering the presence of the triune God through experiential worship that engages the whole person

A Comprehensive Performance Evaluation of Deformable Face Tracking "In-the-Wild"

Recently, technologies such as face detection, facial landmark localisation and face recognition and verification have matured enough to provide effective and efficient solutions for imagery captured under arbitrary conditions (referred to as "in-the-wild"). This is partially attributed to the fact that comprehensive "in-the-wild" benchmarks have been developed for face detection, landmark localisation and recognition/verification. A very important technology that has not been thoroughly evaluated yet is deformable face tracking "in-the-wild". Until now, the performance has mainly been assessed qualitatively by visually assessing the result of a deformable face tracking technology on short videos. In this paper, we perform the first, to the best of our knowledge, thorough evaluation of state-of-the-art deformable face tracking pipelines using the recently introduced 300VW benchmark. We evaluate many different architectures focusing mainly on the task of on-line deformable face tracking. In particular, we compare the following general strategies: (a) generic face detection plus generic facial landmark localisation, (b) generic model free tracking plus generic facial landmark localisation, as well as (c) hybrid approaches using state-of-the-art face detection, model free tracking and facial landmark localisation technologies. Our evaluation reveals future avenues for further research on the topic.Comment: E. Antonakos and P. Snape contributed equally and have joint second authorshi

Automatic construction of robust spherical harmonic subspaces

In this paper we propose a method to automatically recover a class specific low dimensional spherical harmonic basis from a set of in-the-wild facial images. We combine existing techniques for uncalibrated photometric stereo and low rank matrix decompositions in order to robustly recover a combined model of shape and identity. We build this basis without aid from a 3D model and show how it can be combined with recent efficient sparse facial feature localisation techniques to recover dense 3D facial shape. Unlike previous works in the area, our method is very efficient and is an order of magnitude faster to train, taking only a few minutes to build a model with over 2000 images. Furthermore, it can be used for real-time recovery of facial shape

Face flow

In this paper, we propose a method for the robust and efficient computation of multi-frame optical flow in an expressive sequence of facial images. We formulate a novel energy minimisation problem for establishing dense correspondences between a neutral template and every frame of a sequence. We exploit the highly correlated nature of human expressions by representing dense facial motion using a deformation basis. Furthermore, we exploit the even higher correlation between deformations in a given input sequence by imposing a low-rank prior on the coefficients of the deformation basis, yielding temporally consistent optical flow. Our proposed model-based formulation, in conjunction with the inverse compositional strategy and low-rank matrix optimisation that we adopt, leads to a highly efficient algorithm for calculating facial flow. As experimental evaluation, we show quantitative experiments on a challenging novel benchmark of face sequences, with dense ground truth optical flow provided by motion capture data. We also provide qualitative results on a real sequence displaying fast motion and occlusions. Extensive quantitative and qualitative comparisons demonstrate that the proposed method outperforms state-of-the-art optical flow and dense non-rigid registration techniques, whilst running an order of magnitude faster

Disentangling the modes of variation in unlabelled data

Statistical methods are of paramount importance in discovering the modes of variation in visual data. The Principal Component Analysis (PCA) is probably the most prominent method for extracting a single mode of variation in the data. However, in practice, visual data exhibit several modes of variations. For instance, the appearance of faces varies in identity, expression, pose etc. To extract these modes of variations from visual data, several supervised methods, such as the TensorFaces relying on multilinear (tensor) decomposition (e.g., Higher Order SVD) have been developed. The main drawbacks of such methods is that they require both labels regarding the modes of variations and the same number of samples under all modes of variations (e.g., the same face under different expressions, poses etc.). Therefore, their applicability is limited to well-organised data, usually captured in well-controlled conditions. In this paper, we propose a novel general multilinear matrix decomposition method that discovers the multilinear structure of possibly incomplete sets of visual data in unsupervised setting (i.e., without the presence of labels). We also propose extensions of the method with sparsity and low-rank constraints in order to handle noisy data, captured in unconstrained conditions. Besides that, a graph-regularised variant of the method is also developed in order to exploit available geometric or label information for some modes of variations. We demonstrate the applicability of the proposed method in several computer vision tasks, including Shape from Shading (SfS) (in the wild and with occlusion removal), expression transfer, and estimation of surface normals from images captured in the wild

Shale gas reserve evaluation by laboratory pyrolysis and gas holding capacity consistent with field data

Exploration for shale gas occurs in onshore basins, with two approaches used to predict the maximum gas in place (GIP) in the absence of production data. The first estimates adsorbed plus free gas held within pore space, and the second measures gas yields from laboratory pyrolysis experiments on core samples. Here we show the use of sequential high-pressure water pyrolysis (HPWP) to replicate petroleum generation and expulsion in uplifted onshore basins. Compared to anhydrous pyrolysis where oil expulsion is limited, gas yields are much lower, and the gas at high maturity is dry, consistent with actual shales. Gas yields from HPWP of UK Bowland Shales are comparable with those from degassed cores, with the ca. 1% porosity sufficient to accommodate the gas generated. Extrapolating our findings to the whole Bowland Shale, the maximum GIP equate to potentially economically recoverable reserves of less than 10 years of current UK gas consumption

Neuronal Antibodies in Children with or without Narcolepsy following H1N1-AS03 Vaccination

Type 1 narcolepsy is caused by deficiency of hypothalamic orexin/hypocretin. An autoimmune basis is suspected, but no specific antibodies, either causative or as biomarkers, have been identified. However, the AS03 adjuvanted split virion H1N1 (H1N1-AS03) vaccine, created to protect against the 2009 Pandemic, has been implicated as a trigger of narcolepsy particularly in children. Sera and CSFs from 13 H1N1-AS03-vaccinated patients (12 children, 1 young adult) with type 1 narcolepsy were tested for autoantibodies to known neuronal antigens including the N-methyl-D-aspartate receptor (NMDAR) and contactin-associated protein 2 (CASPR2), both associated with encephalopathies that include disordered sleep, to rodent brain tissue including the lateral hypothalamus, and to live hippocampal neurons in culture. When sufficient sample was available, CSF levels of melanin-concentrating hormone (MCH) were measured. Sera from 44 H1N1-ASO3-vaccinated children without narcolepsy were also examined. None of these patients' CSFs or sera was positive for NMDAR or CASPR2 antibodies or binding to neurons; 4/13 sera bound to orexin-neurons in rat brain tissue, but also to other neurons. MCH levels were a marginally raised (n = 8; p = 0.054) in orexin-deficient narcolepsy patients compared with orexin-normal children (n = 6). In the 44 H1N1-AS03-vaccinated healthy children, there was no rise in total IgG levels or in CASPR2 or NMDAR antibodies three weeks following vaccination. In conclusion, there were no narcolepsy-specific autoantibodies identified in type 1 narcolepsy sera or CSFs, and no evidence for a general increase in immune reactivity following H1N1-AS03 vaccination in the healthy children. Antibodies to other neuronal specific membrane targets, with their potential for directing use of immunotherapies, are still an important goal for future research.Peer reviewe

A robust similarity measure for volumetric image registration with outliers

Image registration under challenging realistic conditions is a very important area of research. In this paper, we focus on algorithms that seek to densely align two volumetric images according to a global similarity measure. Despite intensive research in this area, there is still a need for similarity measures that are robust to outliers common to many different types of images. For example, medical image data is often corrupted by intensity inhomogeneities and may contain outliers in the form of pathologies. In this paper we propose a global similarity measure that is robust to both intensity inhomogeneities and outliers without requiring prior knowledge of the type of outliers. We combine the normalised gradients of images with the cosine function and show that it is theoretically robust against a very general class of outliers. Experimentally, we verify the robustness of our measures within two distinct algorithms. Firstly, we embed our similarity measures within a proof-of-concept extension of the Lucas–Kanade algorithm for volumetric data. Finally, we embed our measures within a popular non-rigid alignment framework based on free-form deformations and show it to be robust against both simulated tumours and intensity inhomogeneities

Prostate Cancer Risk by BRCA2 Genomic Regions.

A BRCA2 prostate cancer cluster region (PCCR) was recently proposed (c.7914 to 3') wherein pathogenic variants (PVs) are associated with higher prostate cancer (PCa) risk than PVs elsewhere in the BRCA2 gene. Using a prospective cohort study of 447 male BRCA2 PV carriers recruited in the UK and Ireland from 1998 to 2016, we estimated standardised incidence ratios (SIRs) compared with population incidences and assessed variation in risk by PV location. Carriers of PVs in the PCCR had a PCa SIR of 8.33 (95% confidence interval [CI] 4.46-15.6) and were at a higher risk of PCa than carriers of other BRCA2 PVs (SIR = 3.31, 95% CI 1.97-5.57; hazard ratio = 2.34, 95% CI 1.09-5.03). PCCR PV carriers had an estimated cumulative PCa risk of 44% (95% CI 23-72%) by the age of 75 yr and 78% (95% CI 54-94%) by the age of 85 yr. Our results corroborate the existence of a PCCR in BRCA2 in a prospective cohort. PATIENT SUMMARY: In this report, we investigated whether the risk of prostate cancer for men with a harmful mutation in the BRCA2 gene differs based on where in the gene the mutation is located. We found that men with mutations in one region of BRCA2 had a higher risk of prostate cancer than men with mutations elsewhere in the gene

Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.

BACKGROUND: BRCA1 and BRCA2 mutations have been associated with prostate cancer (PCa) risk but a wide range of risk estimates have been reported that are based on retrospective studies. OBJECTIVE: To estimate relative and absolute PCa risks associated with BRCA1/2 mutations and to assess risk modification by age, family history, and mutation location. DESIGN, SETTING, AND PARTICIPANTS: This was a prospective cohort study of male BRCA1 (n = 376) and BRCA2 carriers (n = 447) identified in clinical genetics centres in the UK and Ireland (median follow-up 5.9 and 5.3 yr, respectively). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Standardised incidence/mortality ratios (SIRs/SMRs) relative to population incidences or mortality rates, absolute risks, and hazard ratios (HRs) were estimated using cohort and survival analysis methods. RESULTS AND LIMITATIONS: Sixteen BRCA1 and 26 BRCA2 carriers were diagnosed with PCa during follow-up. BRCA2 carriers had an SIR of 4.45 (95% confidence interval [CI] 2.99-6.61) and absolute PCa risk of 27% (95% CI 17-41%) and 60% (95% CI 43-78%) by ages 75 and 85 yr, respectively. For BRCA1 carriers, the overall SIR was 2.35 (95% CI 1.43-3.88); the corresponding SIR at age <65 yr was 3.57 (95% CI 1.68-7.58). However, the BRCA1 SIR varied between 0.74 and 2.83 in sensitivity analyses to assess potential screening effects. PCa risk for BRCA2 carriers increased with family history (HR per affected relative 1.68, 95% CI 0.99-2.85). BRCA2 mutations in the region bounded by positions c.2831 and c.6401 were associated with an SIR of 2.46 (95% CI 1.07-5.64) compared to population incidences, corresponding to lower PCa risk (HR 0.37, 95% CI 0.14-0.96) than for mutations outside the region. BRCA2 carriers had a stronger association with Gleason score ≥7 (SIR 5.07, 95% CI 3.20-8.02) than Gleason score ≤6 PCa (SIR 3.03, 95% CI 1.24-7.44), and a higher risk of death from PCa (SMR 3.85, 95% CI 1.44-10.3). Limitations include potential screening effects for these known mutation carriers; however, the BRCA2 results were robust to multiple sensitivity analyses. CONCLUSIONS: The results substantiate PCa risk patterns indicated by retrospective analyses for BRCA2 carriers, including further evidence of association with aggressive PCa, and give some support for a weaker association in BRCA1 carriers. PATIENT SUMMARY: In this study we followed unaffected men known to carry mutations in the BRCA1 and BRCA2 genes to investigate whether they are at higher risk of developing prostate cancer compared to the general population. We found that carriers of BRCA2 mutations have a high risk of developing prostate cancer, particularly more aggressive prostate cancer, and that this risk varies by family history of prostate cancer and the location of the mutation within the gene